Cefuroxime Axetil is a second generation cephalosporin, this is an ester of cefuroxime which is effective orally. Cefuroxime axetil is an oral cephalosporin which is rapidly hydrolysed to the active parent compound, cefuroxime. Cefuroxime has a broad spectrum of in vitro antibacterial activity. Cefuroxime has broad spectrum activity against the beta-lactamase positive respiratory pathogens H. influenzae and M. catarrhalis; it is also active against penicillin-susceptible and -intermediate strains of S. pneumoniae. Cefuroxime axetil has been evaluated in the treatment of upper and lower respiratory tract infections.
Clavulanic Acid is a beta-lactamase inhibitor which reduces resistance and enhances the activity of Cefuroxime axetil against bacteria.
High cure rates (85 to 95 %) In Pneumonia, Acute bronchitis, Bacterial sinusitis, Urinary Tract Infections, Skin & soft tissue infections and prevents Post-surgical infections